Agenovir is a leader in the research and development of a novel class of human therapeutics to address diseases associated with, or caused by, latent or persistent viral reservoirs. The individuals affected by these diseases number in the millions, and treatment options are extremely limited or non-existent.
View Top Employees from Agenovir Corporation| Website | https://www.agenovir.com/ |
| Revenue | $6.2 million |
| Funding | $10.6 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2014 |
| Address | 329 Oyster Point Blvd. 3Rd Fl, South San Francisco, California 94080, US |
| Phone | (650) 491-9624 |
| Category | Biotechnology, Therapeutic Devices, Pharmaceuticals, Healthcare |
| Competitors | Cocrystal Pharma, Inc., Integrated BioTherapeutics, Inc., NexImmune, Inc., Prosetta Corporation |
| SIC | 283, 28 |
| NAICS | 3254, 325, 32 |
Looking for a particular Agenovir Corporation employee's phone or email?
Agenovir Corporation Questions
The Agenovir Corporation annual revenue was $6.2 million in 2023.
Agenovir Corporation is based in South San Francisco, California.
The NAICS codes for Agenovir Corporation are [3254, 325, 32].
The SIC codes for Agenovir Corporation are [283, 28].
Related Companies
